期刊文献+

聚乙二醇沉淀法和离子交换层析法纯化人凝血因子Ⅷ效果的比较 被引量:1

Comparison of purification effects on human coagulation factor Ⅷ by polyethylene glycol precipitation and ion exchange chromatography
原文传递
导出
摘要 目的 比较聚乙二醇(polyethylene glycol,PEG)沉淀法和离子交换层析法纯化人凝血因子Ⅷ(human coagulation factor Ⅷ,FⅧ)制品的效果。方法 分别采用PEG沉淀法和离子交换层析法纯化工艺制备各3批FⅧ,按照中国药典2015年版三部的要求检测各项质量指标,比较两种纯化工艺生产的FⅧ的回收率以及相关质量指标。结果 离子交换层析法和PEG沉淀法纯化的FⅧ的回收率分别为68.25%和29.90%,成品比活分别为61.8和3.8 IU/mg,成品磷酸三丁酯残留量分别为0.8和4.0μg/ml。结论 以离子交换层析法纯化FⅧ能有效提高制品质量,且更适合规模化生产。 Objective To compare purification effect on human coagulation factor Ⅷ(FⅧ) between polyethylene glycol (PEG) precipitation and ion exchange chromatography. Methods Three batches of FⅧ each were purified with PEG precipitation and ion exchange chromatography, respectively. Each quality index test was carried out according to Chinese Pharmacopoeia 2015 (volume Ⅲ). The recoveries and relative quality indexes of FⅧ purified by 2 purification processes were compared. Results The recoveries of FⅧ purified by PEG precipitation and ion exchange chromatography were 29.90% and 68.25%, respectively. The specific activity and the tributyl phosphate residual amount of final FⅧ product were 3.8 IU/mg and 4.0μg/ml with PEG precipitation, and 61.8 IU/mg and 0.8 μg/ml with ion exchange chromatography. Conclusion FⅧ purification with ion exchange chromatography can improve FⅧ quality effectively, and is more suitable for large scale production.
出处 《国际生物制品学杂志》 CAS 2017年第6期279-281,共3页 International Journal of Biologicals
关键词 因子Ⅷ 色谱法 离子交换 化学沉淀 Factor Ⅷ Chromatography, ion exchange Chemical precipitation
  • 相关文献

参考文献3

二级参考文献29

  • 1Brooker M. Registry of Clotting Factor Concentrates [M]. Eighth Edition. Montr6al, Qu6bec, Canada: World Federation of Hemo- philia, 2008.
  • 2Wagner BH, McLester WD, Smith M, et o2. Purification of anti- hemophilic factor (factor V) by amino acid precipitation [J]. Thromh Diath Haemorrh, 1964, 11 (1): 64-74.
  • 3Newman J, Johnson AJ, Karpatkin MH, et al. Methods for the production of clinically effective intermediate- and high-purity factor-V concentrates [J]. Br J Haematol, 1971, 21 ( 1 ): 1-20.
  • 4Burnouf T, Bumouf-Radosevich M, Huart JJ, et o/. A highly purified faetor V:c concentrate prepared from cryoprecipitate by ion-exchange chromatography [J]. Vox Sang, 1991, 60 (1): 8- 15.
  • 5Cheng E, Jinzenji D, Lorthiois AP, et al. Purification of coagu- lation factor V using chromatographic methods. Direct chroma- tography of plasma in anion exchange resins [J]. Biotechnol Lett, 2010, 32 (9): 1207-1214.
  • 6Teh LC, Froger M. Direct capture of plasma factor vm:c by ion exchange chromatography [J]. Vox Sang, 1994, 67 ( 1 ): 8-13.
  • 7Kaersgaard P, Barington KA. Isolation of the factor VW-von Willebrand factor complex directly from plasma by gel filtration [J]. J Chromatogr B Biomed Sci Appl, 1998, 715 (2): 357-367.
  • 8Teh LC. Preparation of intermediate-purity factor V concentrate by direct gel filtration of cryoprecipitate [J]. Vox Sang, 1993, 65 (4): 251-257.
  • 9Wadsworth C, Blomback M, Kjellman H, et ol. Complexes of IgG and plasma proteins in factor Vm preparations-a possible cause of adverse reactions [J]. Vox Sang, 1985, 49 (5): 319-322.
  • 10Vlot AJ, Koppelman SJ, Van Den Berg MH, et ol. The affinity and stoiehiometry of binding of human factor VIII to yon Willebrand factor [J]. Blood, 1995, 85 ( 11 ): 3150-3157.

共引文献13

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部